- Home
- RLAY vs DMLP Comparison
RLAY vs DMLP Comparison
Compare RLAY & DMLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RLAY | DMLP |
|---|---|---|
| Founded | 2015 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.1B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | RLAY | DMLP |
|---|---|---|
| Price | $8.66 | $22.26 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $16.00 | N/A |
| AVG Volume (30 Days) | ★ 2.3M | 250.9K |
| Earning Date | 11-06-2025 | 11-06-2025 |
| Dividend Yield | N/A | ★ 14.51% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.13 |
| Revenue | $8,355,000.00 | ★ $143,803,000.00 |
| Revenue This Year | $20.47 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $19.72 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.78 | $20.85 |
| 52 Week High | $9.04 | $34.88 |
Technical Indicators
Market Signals| Indicator | RLAY | DMLP |
|---|---|---|
| Relative Strength Index (RSI) | 66.58 | 46.01 |
| Support Level | $7.95 | $21.37 |
| Resistance Level | $9.04 | $22.43 |
| Average True Range (ATR) | 0.50 | 0.62 |
| MACD | 0.04 | 0.05 |
| Stochastic Oscillator | 77.78 | 44.99 |
Price Performance
Historical ComparisonAbout RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).
About DMLP Dorchester Minerals L.P.
Dorchester Minerals LP operates as the owner of producing and non-producing crude oil and natural gas mineral, royalty, overriding royalty, net profits and leasehold interests. The company generates revenues from royalties, net profits interests, lease bonus, and others. It has leasehold interests in approximately 592 counties and parishes in around 28 states.